Monday, October 30, 2006 5:46:19 PM
Resumption ID
Halt
Date Halt
Time Issue
Symbol Issue Name Mkt Reason
Code Date Quote
Time Trade
Time
10/30/2006 16:38:30 RNAI Sirna Therapeutics Inc N T3 10/30/2006 17:05:00 17:10:00
4:35PM Sirna Therapeutics: Merck to acquire Sirna Therapeutics for $13/share (RNAI) 6.45 -0.04 : Merck (MRK) and RNAI announce that they have entered into a definitive agreement under which MRK will acquire RNAI. Under the terms of the agreement, MRK will acquire through a merger 100% of the equity of RNAI at a price of $13 per share in cash, making RNAI a wholly owned subsidiary of MRK. The transaction has a cash value of approximately $1.1 bln.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM